(Q51501369)

English

A mechanism-based disease progression model for comparison of long-term effects of pioglitazone, metformin and gliclazide on disease processes underlying Type 2 Diabetes Mellitus.

scientific article published on 22 March 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/16552630

A mechanism-based disease progression model for comparison of long-term effects of pioglitazone, metformin and gliclazide on disease processes underlying Type 2 Diabetes Mellitus. (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/16552630

type 2 diabetes

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/16552630

Meindert Danhof

8

object named as

Meindert Danhof

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/16552630

author name string

Willem de Winter

1

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/16552630

Teun Post

3

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/16552630

Bart Ploeger

4

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/16552630

Richard Urquhart

5

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/16552630

Ian Moules

6

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/16552630

David Eckland

7

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/16552630

publication date

22 March 2006

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/16552630

Journal of Pharmacokinetics and Pharmacodynamics

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/16552630

33

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/16552630

3

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/16552630

313-343

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/16552630

https://scigraph.springernature.com/pub.10.1007/s10928-006-9008-2

0 references

Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.

1 reference

https://api.crossref.org/works/10.1007%2FS10928-006-9008-2

21 January 2018

Pharmacologic therapy for type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2FS10928-006-9008-2

21 January 2018

Role of AMP-activated protein kinase in mechanism of metformin action

1 reference

https://api.crossref.org/works/10.1007%2FS10928-006-9008-2

21 January 2018

Population PKPD modelling of the long-term hypoglycaemic effect of gliclazide given as a once-a-day modified release (MR) formulation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16552630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of pioglitazone and gliclazide in sustaining glycemic control over 2 years in patients with type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/16552630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use and abuse of HOMA modeling

1 reference

https://pubmed.ncbi.nlm.nih.gov/16552630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug treatment effects on disease progression.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16552630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Standards of medical care in diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/16552630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/16552630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/16552630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Disease system analysis: basic disease progression models in degenerative disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/16552630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral antihyperglycemic therapy for type 2 diabetes: scientific review

1 reference

https://pubmed.ncbi.nlm.nih.gov/16552630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathophysiology and pharmacological treatment of insulin resistance

1 reference

https://pubmed.ncbi.nlm.nih.gov/16552630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of four basic models of indirect pharmacodynamic responses

1 reference

https://pubmed.ncbi.nlm.nih.gov/16552630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: a 6-month randomized placebo-controlled dose-response study. The Pioglitazone 001 Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16552630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanism-based pharmacokinetic-pharmacodynamic modeling-a new classification of biomarkers

1 reference

https://pubmed.ncbi.nlm.nih.gov/16552630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methodologic aspects of a population pharmacodynamic model for cognitive effects in Alzheimer patients treated with tacrine.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16552630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16552630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of insulin resistance with peroxisome proliferator-activated receptor gamma agonists

1 reference

https://pubmed.ncbi.nlm.nih.gov/16552630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluating pharmacokinetic/pharmacodynamic models using the posterior predictive check

1 reference

https://pubmed.ncbi.nlm.nih.gov/16552630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of pioglitazone versus metformin in patients with type 2 diabetes mellitus: a double-blind, randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/16552630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A long-term comparison of pioglitazone and gliclazide in patients with Type 2 diabetes mellitus: a randomized, double-blind, parallel-group comparison trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/16552630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/16552630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10928-006-9008-2

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/16552630

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/16552630

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51501369&oldid=2143454468"